TEL AVIV (Reuters) - Israel-based DreaMed Diabetes said on Monday it had licensed its artificial pancreas technology for integration into insulin pumps made by Medtronic.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment